# Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2

> **NCT03346499** · PHASE1 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 4 (actual)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** NK cells and IL-2

## Key facts

- **NCT ID:** NCT03346499
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-09
- **Primary completion:** 2018-11-13
- **Final completion:** 2018-11-13
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346499, "Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03346499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*